 Vasoconstrictor Agents
"Vasoconstrictor Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to cause constriction of the blood vessels.
| Descriptor ID |
D014662
|
| MeSH Number(s) |
D27.505.954.411.793
|
| Concept/Terms |
Vasoconstrictor Agents- Vasoconstrictor Agents
- Agents, Vasoconstrictor
- Vasoconstrictor Drugs
- Drugs, Vasoconstrictor
- Vasoconstrictors
- Vasoactive Agonists
- Agonists, Vasoactive
- Vasopressor Agents
- Agents, Vasopressor
|
Below are MeSH descriptors whose meaning is more general than "Vasoconstrictor Agents".
Below are MeSH descriptors whose meaning is more specific than "Vasoconstrictor Agents".
This graph shows the total number of publications written about "Vasoconstrictor Agents" by people in this website by year, and whether "Vasoconstrictor Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1998 | 1 | 0 | 1 | | 1999 | 0 | 2 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 0 | 3 | 3 | | 2003 | 1 | 1 | 2 | | 2004 | 2 | 1 | 3 | | 2005 | 1 | 0 | 1 | | 2006 | 1 | 2 | 3 | | 2007 | 0 | 2 | 2 | | 2008 | 0 | 4 | 4 | | 2009 | 4 | 1 | 5 | | 2010 | 0 | 4 | 4 | | 2011 | 1 | 3 | 4 | | 2012 | 4 | 2 | 6 | | 2013 | 1 | 1 | 2 | | 2014 | 2 | 0 | 2 | | 2015 | 0 | 2 | 2 | | 2016 | 0 | 1 | 1 | | 2017 | 0 | 3 | 3 | | 2018 | 2 | 2 | 4 | | 2019 | 2 | 4 | 6 | | 2020 | 4 | 5 | 9 | | 2021 | 0 | 6 | 6 | | 2022 | 0 | 3 | 3 | | 2023 | 2 | 2 | 4 | | 2024 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Vasoconstrictor Agents" by people in Profiles.
-
Ray L, Acquisto NM, Coralic Z, Feldman R, Mercer K, Zimmerman DE, Howington GT, Slocum GW, Faine B, Rech MA. A national survey of medication utilization for cardiac resuscitation in the emergency department: A survey of emergency medicine pharmacists. Am J Health Syst Pharm. 2024 Dec 05; 81(24):1313-1321.
-
Busse LW, Teixeira JP, Schaich CL, Ten Lohuis CC, Nielsen ND, Sturek JM, Merck LH, Self WH, Puskarich MA, Khan A, Semler MW, Moskowitz A, Hager DN, Duggal A, Rice TW, Ginde AA, Tiffany BR, Iovine NM, Chen P, Safdar B, Gibbs KW, Javaheri A, de Wit M, Harkins MS, Joly MM, Collins SP. Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19. J Crit Care. 2025 Feb; 85:154950.
-
Hasson DC, Gist KM, Seo J, Stenson EK, Kessel A, Haga T, LaFever S, Santiago MJ, Barhight M, Selewski D, Ricci Z, Ollberding NJ, Stanski NL. The Association Between Vasopressin and Adverse Kidney Outcomes in Children and Young Adults Requiring Vasopressors on Continuous Renal Replacement Therapy. Crit Care Explor. 2024 Oct; 6(10):e1156.
-
Kienzle MF, Morgan RW, Reeder RW, Ahmed T, Berg RA, Bishop R, Bochkoris M, Carcillo JA, Carpenter TC, Cooper KK, Diddle JW, Federman M, Fernandez R, Franzon D, Frazier AH, Friess SH, Frizzola M, Graham K, Hall M, Horvat C, Huard LL, Maa T, Manga A, McQuillen PS, Meert KL, Mourani PM, Nadkarni VM, Naim MY, Pollack MM, Sapru A, Schneiter C, Sharron MP, Tabbutt S, Viteri S, Wolfe HA, Sutton RM. Epinephrine Dosing Intervals Are Associated With Pediatric In-Hospital Cardiac Arrest Outcomes: A Multicenter Study. Crit Care Med. 2024 Sep 01; 52(9):1344-1355.
-
Lawson CK, Faine BA, Rech MA, Childs CA, Brown CS, Slocum GW, Acquisto NM, Ray L. Norepinephrine versus epinephrine for hemodynamic support in post-cardiac arrest shock: A systematic review. Am J Emerg Med. 2024 03; 77:158-163.
-
Stefanos SS, Kiser TH, MacLaren R, Mueller SW, Reynolds PM. Management of noncytotoxic extravasation injuries: A focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline. Pharmacotherapy. 2023 04; 43(4):321-337.
-
Wenner MM, Welti LM, Dow CA, Greiner JJ, Stauffer BL, DeSouza CA. Aerobic exercise training reduces ET-1-mediated vasoconstriction and improves endothelium-dependent vasodilation in postmenopausal women. Am J Physiol Heart Circ Physiol. 2023 06 01; 324(6):H732-H738.
-
Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, Ginde AA, Gong MN, Grissom CK, Hayden D, Hough CL, Huang W, Iwashyna TJ, Jones AE, Khan A, Lai P, Liu KD, Miller CD, Oldmixon K, Park PK, Rice TW, Ringwood N, Semler MW, Steingrub JS, Talmor D, Thompson BT, Yealy DM, Self WH. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension. N Engl J Med. 2023 02 09; 388(6):499-510.
-
Roberts DS, Sherlock LG, Posey JN, Archambault JL, Nozik ES, Delaney CA. Serotonin-deficient neonatal mice are not protected against the development of experimental bronchopulmonary dysplasia or pulmonary hypertension. Physiol Rep. 2022 10; 10(19):e15482.
-
Sacha GL, Kiser TH, Wright GC, Vandivier RW, Moss M, Burnham EL, Ho PM, Reynolds PM, Bauer SR. Association Between Vasopressin Rebranding and Utilization in Patients With Septic Shock. Crit Care Med. 2022 04 01; 50(4):644-654.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|